Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Decitabine Priming Expands Progenitor Tex Under Anti–PD-1
2026-08-12
The reference study shows that low-dose decitabine can improve anti–PD-1 efficacy by expanding and sustaining proliferative CD8+ progenitor exhausted T cells rather than merely activating terminally exhausted populations. Its integrated tumor, transcriptional, epigenetic, and mechanistic analyses identify sustained JunD/AP-1 activity as a potential explanation for improved T cell persistence and tumor control.
-
Bafilomycin C1 in High-Content Cell Assays
2026-08-12
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal acidification to interpretable phenotypic screening. This guide shows how to use its mechanism as a deliberate assay control alongside deep-learning analysis, autophagy measurements, and cardiomyocyte safety workflows.
-
Indole-3-pyruvic acid: Bench Workflows
2026-08-11
Indole-3-pyruvic acid connects mechanistic plant auxin studies with carefully controlled immune-cell assays. This practical guide covers TAA1 feedback experiments, fresh-solution handling, PBMC dose planning, and troubleshooting across plant, fungal, and mammalian workflows.
-
10 mM dNTP Mixture: Assay Design for LNP DNA Studies
2026-08-11
Learn how a 10 mM dNTP mixture can strengthen DNA amplification, sequencing, and control design in lipid nanoparticle studies. This article connects reproducible nucleotide handling with mechanistic lessons from research on cholesterol-dependent intracellular trafficking.
-
EGCG Nanoparticles Enhance FLASH-RT Antitumor Effects
2026-08-10
Xu et al. report that functionalized, self-assembled epigallocatechin gallate nanoparticles enhance FLASH-RT by increasing radiation-associated oxidative stress and tumor-cell DNA damage while promoting antitumor immune responses. The study provides a preclinical framework for combining nanomedicine, ultra-high-dose-rate radiotherapy, and immune profiling, although clinical transferability remains unresolved.
-
Bifendate (DDB): From Omics to Assay Design
2026-08-09
Bifendate (DDB) is more than a conventional hepatoprotection agent: its value lies in connecting liver-injury phenotypes with multiomics-defined regulatory modules. This guide translates those findings into better assay selection, dosing logic, and interpretation.
-
From Field Images to Molecular Validation
2026-08-08
Deep-learning image analysis can accelerate sweetpotato virus disease screening, but translational programs still need an orthogonal molecular layer. This article explains how endpoint PCR, TA-cloning compatibility, and direct gel loading can turn field observations into reproducible validation workflows.
-
2X Taq PCR Master Mix for Plant Virus Workflows
2026-08-07
Use a streamlined Taq workflow to move from plant-sample genotyping and cloning to gel-ready amplicon analysis, while recognizing that image-based disease screening and molecular confirmation answer different questions. The dye-containing formulation reduces pipetting steps, and its adenine-overhang chemistry supports practical TA-cloning workflows.
-
VE-821: ATR Kinase Inhibition Unveils New Horizons in DDR an
2026-08-07
Discover how VE-821, a potent ATR kinase inhibitor, is redefining DNA damage response research and unlocking novel insights into viral epigenetic regulation. This in-depth analysis explores the compound’s unique mechanistic advantages, advanced protocol guidance, and implications for cross-domain studies.
-
Jiedu Xiaozheng Yin Drives M1 Macrophage Shift in Colitis-CR
2026-08-06
Liu et al. provide mechanistic evidence that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer by promoting M1 macrophage polarization via the TLR4 pathway. These findings clarify immune microenvironment modulation as a strategy for tumor suppression and offer a framework for dissecting transcriptional regulation in cancer models.
-
Validating Fungal Symbionts in Xyleborus affinis: Koch-Like
2026-08-06
This study advances our understanding of fungal-animal mutualism by systematically isolating and verifying new and known fungal symbionts within Xyleborus affinis ambrosia beetles. By refining mycangial isolation protocols and fulfilling Koch-like postulates for mutualists, the research sets a new standard for characterizing complex beetle–fungal associations.
-
Sodium phosphate dibasic: Reliable Buffering in Cell Viabili
2026-08-05
Inconsistencies in cell viability and cytotoxicity assays often stem from unstable buffer conditions. This authoritative article explores how Sodium phosphate dibasic (SKU B7293) from APExBIO addresses these challenges through scenario-driven Q&A, data-backed recommendations, and validated workflows. Practical guidance is provided for biomedical researchers and lab technicians aiming to enhance reproducibility and assay sensitivity.
-
10 mM dNTP Mixture: Precision DNA Synthesis for Reliable PCR
2026-08-05
The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture delivers unmatched reproducibility for PCR, DNA sequencing, and nucleic acid tracking workflows. Explore evidence-driven protocol enhancements, troubleshooting strategies, and practical insights that distinguish this APExBIO molecular biology reagent from commodity alternatives.
-
GABRA1 Frameshift Variants Disrupt GABAA Receptor Proteostas
2026-08-04
This study systematically characterizes four clinical frameshift variants in the GABRA1 gene and demonstrates their distinct impacts on GABAA receptor folding, trafficking, and proteostasis. The findings clarify mechanisms underlying genetic epilepsy and highlight the value of proteasome inhibition tools for dissecting ER quality control.
-
PR-619: Broad-Spectrum Deubiquitylating Enzymes Inhibitor In
2026-08-04
PR-619 is a potent, reversible deubiquitylating enzymes inhibitor with broad specificity and application in ubiquitination pathway research. Its unique mechanism allows accumulation of ubiquitinated proteins without proteasome inhibition, making it a valuable tool in cancer biology and neurodegenerative disease models.